> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Revision on CLIA Waivers
- URL: https://www.fdaweb.com/info-collection-revision-on-clia-waivers/
- Published: 2022-06-16T12:00:00.000Z
- Updated: 2026-09-14T17:49:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152085

*Federal Register* notice: FDA is seeking comments on an information collection revision entitled “Administrative Procedures for Clinical Laboratory Improvement Amendments of 1988” (OMB Control Number 0910-0607). The revision pertains to the inclusion of provisions associated with certificates of waiver. In 2020, FDA revised the guidance document entitled “Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices,” which describes recommendations for device manufacturers submitting to FDA an application for determination that a cleared or approved device meets this CLIA standard (CLIA waiver application). To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-06-16/pdf/2022-12929.pdf?ref=fdaweb.com).